AACC uses Cookies to ensure the best website experience. Continuing without changing Cookie settings assumes you consent to our use of cookies on this device. You can change these settings at any time, but that may impair functionality on our websites. Review our cookie and privacy policy

SARS-CoV-2 2021: A Panel Discussion on Impact of SARS-CoV-2 and Near-Future Considerations

  • Credit:1.0 ACCENT Credit
  • Duration: 1 hour
  • Date:NOV.24.2020 1:00 PM - 02:00 PM
  • Level: Intermediate

Price: $0.00

Member Price: $0.00

Register for this webinar, recorded on November 24, 2020, to hear where we may be in the upcoming year. With your registration, you will have access to the recording on demand through November 30, 2021.

DESCRIPTION

As we approach the end of year, we need to look forward. The unique challenges of SARS-CoV-2 and SARS-CoV-2 testing this past year will provide some insight into what we need to think about going into a new year. What will we expect after this influenza season and what impact will that have for the population and vaccine development? The panelist will share their unique insights and what key role we all serve in the fight going forward.

TARGET AUDIENCE

This activity is designed for lab supervisors, lab directors (and/or assistant directors), lab managers (supervisory and/or non-supervisory), point-of-care coordinators, and other laboratory professionals overseeing and/or carrying out SARS-CoV-2 testing.

LEARNING OBJECTIVES

At the end of this activity, participants will be able to:

  • Describe potential future challenges of laboratory professionals and the broader healthcare community with SARS-CoV-2 testing.
  • Discuss the continuing role of laboratory medicine in the testing, treatment, and management of SARS-CoV-2.

FACULTY

Moderators

Nina Babic HeadshotNikolina Babic, PhD, DABCC, FAACC
Director of Clinical Chemistry & Toxicology Medical
University of South Carolina
Charleston, SC, USA

Y. Victoria Zhang, PhD, MBA, DABCC, FAACC
Associate Professor  and Vice Chair for Clinical Enterprise Strategy,  Director of Clinical Chemistry Division, Department of Pathology and Laboratory Medicine
University of Rochester Medical Center
Rochester, NY, USA

Panelists:

Scott Curry HeadshotScott R. Curry, MD
Assistant Professor and Infectious Disease Specialist
Medical University of South Carolina
Charleston, SC, USA

Frederick Nolte HeadshotFrederick S. Nolte, PhD, D(ABMM), F(AAM)
Professor and Vice Chair for Laboratory Medicine
Medical University of South Carolina
Charleston, SC, USA

Matthew Pettengill HeadshotMatthew Pettengill, PhD, D (ABMM)
Scientific Director of Clinical Microbiology
Thomas Jefferson University Hospital
Philadelphia, PA, USA

Eline PrakEline T. Luning Prak, MD, PhD
Professor of Pathology and Laboratory Medicine
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA, USA

Ping Wang headshotPing Wang, PhD, DABCC, FAACC
Professor of Pathology and Laboratory Medicine
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA, USA

DISCLOSURES AND STATEMENT OF INDEPENDENCE

AACC is dedicated to ensuring balance, independence, objectivity, and scientific rigor in all educational activities. All participating planning committee members and faculty are required to disclose to the program audience any financial relationships related to the subject matter of this program. Disclosure information is reviewed in advance in order to manage and resolve any possible conflicts of interest. The intent of this disclosure is to provide participants with information on which they can make their own judgments.

The following faculty reported the following relevant financial relationship(s) during the content development process for this activity:

  • Scott R. Curry, MD
    • Grant/Research Support: Cepheid
    • Board/Committee Membership/Advisory Board: Ferring Pharmaceuticals
  • Frederick S. Nolte, PhD, D(ABMM), F(AAM)
    • Grant/Research Support: BioFire
    • Presenter/Speaker Honoraria: Abbott Molecular, Abbott, Roche, BioFire
  • Eline T. Luning Prak, MD, PhD
    • Research/Grant Support: Janssen Research and Development, sponsored research grant to study antibody repertoires
    • Consultant Fees: Enpicom, paid consultant; Roche Diagnostics, paid consultant, virtual COVID advisory board
    • Salary:  Janssen sponsored research grant
    • Board/Committee Membership/Advisory Board: Member, SAB The Antibody Society; Member, SAB Enpicom; Member SAB American Autoimmune-Related Diseases Association
  • Ping Wang, PhD, DABCC, FAACC
    • Intellectual Property/Royalty Income: Inventor of Microbubbling Digital Assay

The following faculty and reviewers reported no relevant financial relationship:

  • Matthew Pettengill, PhD, D (ABMM)
  • Nikolina Babic, PhD, DABCC, FAACC
  • Y. Victoria Zhang, PhD, MBA, DABCC, FAACC

CONTENT VALIDITY

All recommendations involving clinical medicine are based on evidence accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients; AND/OR All scientific research referred to or reported in support or justification of a patient care recommendation conforms to generally accepted standards of experimental design, data collection, and analysis.

ACCREDITATION STATEMENT

This activity is approved for 1.0 ACCENT® continuing education credits. Activity ID# 2049. This activity was planned in accordance with ACCENT® Standards and Policies.

SUCCESSFUL COMPLETION STATEMENT

Verification of Participation certificates are provided to registered participants based on completion of the activity, in its entirety, and the activity evaluation. For questions regarding continuing education, please email education@aacc.org.